X

CJC-1295 with DAC / 2 mg

28,00 €

CJC-1295 with DAC / 2 mg is a research-grade long-acting GHRH analogue supplied in lyophilised form for laboratory use. By incorporating a Drug Affinity Complex (DAC), it remains active for several days, making it one of the best-known peptides for sustained growth hormone and IGF-1 research.

Purity ≥99% | Buy in Europe with shipping from €5 | Free shipping upgrades available | Card payments accepted

Available

Description

CJC-1295 with DAC is a modified analogue of Growth Hormone Releasing Hormone (GHRH) engineered to dramatically extend its duration of action.


Product characteristics

SpecificationDetails
ProductCJC-1295 with DAC
Quantity2 mg per vial
FormLyophilised powder
Purity≥99.64% (HPLC tested)
Molecular formula:C165H269N47O46
Molecular weight3647.65 g/mol
StorageRefrigerated at 2–8°C
Intended applicationLaboratory and analytical research

Quality control

Current batch: CWD2-A0612

  • Internal HPLC purity: 99.64%

View Certificate of Analysis.


Further information

CJC-1295 belongs to the GHRH analogue and growth hormone signaling research class. For a broader overview of GH signaling pathways and comparative peptide mechanisms, see our Growth hormone peptides research guide and the CJC-1295 DAC vs no DAC article.

For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Related products